Emcure Pharmaceuticals Limited — Board Meeting, 07-11-2024: Outcome of Board Meeting

Emcure Pharmaceuticals reported a strong financial performance for the quarter ending September 30, 2024, achieving a revenue of ₹2,002 crore, up 20.4% YoY. Profits after tax rose 38.2% YoY to ₹202 crore. The domestic business grew 15.4%, while international sales surged 25%. The company continues to integrate its recent acquisitions and partnerships to drive further growth in both domestic and international markets. Plans to enhance margins through operational efficiencies are underway.